Evvy raises $40M as it seeks to further women’s health research with vaginal microbiome data
Evvy, a women’s health company, announced a $40 million Series B funding round led by Catalio Capital Management, signaling continued investor interest in its health-focused offerings and growth plans.
MAIN POINTS
- Evvy raised $40 million in a Series B financing round.
- Catalio Capital Management led the investment.
- The company operates in the women’s health sector.
- The announcement was made on Tuesday.
TAKEAWAYS
- The funding suggests strong market confidence in women’s health startups.
- A Series B round typically supports scaling operations and product development.
- Catalio’s leadership may help attract additional strategic investors.
- Evvy appears positioned for further expansion after this capital raise.